A follow-up survey led by Professor Takaaki Nakata of Chiba University Graduate School of Medicine and Assistant Professor Takehiko Oami of Chiba University Hospital has revealed that sepsis treatment in Japan, which has been on the rise in recent years, is becoming more cost-effective. .
According to Chiba University, Professor Nakata and his colleagues collected blood cultures from 2010 to 2017 from the database of the Comprehensive Medical Fee Evaluation System and extracted patients who received antibiotics. , and calculated the total cost of examinations and treatments.
As a result, it was found that the number of sepsis patients continued to increase from 2010 to 2017, and the annual medical expenses increased from 3,515 billion yen to 5,050 billion yen.However, it became clear that the medical expenses per admission and the length of stay in the hospital for sepsis patients have been declining year by year, and that the cost per person has fallen from nearly 1 million yen to nearly 1 million yen.
However, in 75, medical expenses for people aged 2017 and over accounted for more than 50% of the total, and the growth rate was higher than for other generations.
Sepsis is a disease in which the body's excessive reaction to bacteria and viruses damages its own cells and reduces organ function.According to overseas data, approximately 3,000 million people develop sepsis each year, one-third die from severe organ damage, and many patients who survive treatment suffer from chronic organ damage.
Paper information:[Journal of Intensive Care] Temporal trends of medical cost and cost-effectiveness in sepsis patients: a Japanese nationwide medical claims database
